Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.

Autor: Bazinet M; Replicor Inc.MontrealCanada., Anderson M; Abbott DiagnosticsAbbott ParkILUSA., Pântea V; Department of Infectious DiseasesNicolae Testemiţanu State University of Medicine and PharmacyChișinăuRepublic of Moldova., Placinta G; Department of Infectious DiseasesNicolae Testemiţanu State University of Medicine and PharmacyChișinăuRepublic of Moldova., Moscalu I; ARENSIA Exploratory MedicineRepublican Clinical HospitalChișinăuRepublic of Moldova., Cebotarescu V; Department of Infectious DiseasesNicolae Testemiţanu State University of Medicine and PharmacyChișinăuRepublic of Moldova., Cojuhari L; Department of Infectious DiseasesNicolae Testemiţanu State University of Medicine and PharmacyChișinăuRepublic of Moldova., Jimbei P; Toma Ciorbǎ Infectious Clinical HospitalChișinăuRepublic of Moldova., Iarovoi L; Department of Infectious DiseasesNicolae Testemiţanu State University of Medicine and PharmacyChișinăuRepublic of Moldova., Smesnoi V; Toma Ciorbǎ Infectious Clinical HospitalChișinăuRepublic of Moldova., Musteata T; Toma Ciorbǎ Infectious Clinical HospitalChișinăuRepublic of Moldova., Jucov A; Department of Infectious DiseasesNicolae Testemiţanu State University of Medicine and PharmacyChișinăuRepublic of Moldova.; ARENSIA Exploratory MedicineRepublican Clinical HospitalChișinăuRepublic of Moldova., Dittmer U; Institute for VirologyUniversity of Duisburg-EssenEssenGermany., Gersch J; Abbott DiagnosticsAbbott ParkILUSA., Holzmayer V; Abbott DiagnosticsAbbott ParkILUSA., Kuhns M; Abbott DiagnosticsAbbott ParkILUSA., Cloherty G; Abbott DiagnosticsAbbott ParkILUSA., Vaillant A; Replicor Inc.MontrealCanada.

Publikováno v: Hepatology communications [Hepatol Commun] 2021 Nov; Vol. 5 (11), pp. 1873-1887. Date of Electronic Publication: 2021 Jul 10.

Targeting Subviral Particles: A Critical Step in Achieving HBV Functional Cure but Where Are We with Current Agents in Clinical Development?

Autor: Vaillant, Andrew¹ (AUTHOR) availlant@replicor.com

Publikováno v: Viruses (1999-4915). Jun2022, Vol. 14 Issue 6, pN.PAG-N.PAG. 5p.

Updated Follow-up Analysis in the REP 401 Protocol : Treatment of HBeAg Negative Chronic HBV Infection with REP 2139 or REP 2165, Tenofovir Disoproxil Fumarate and Pegylated Interferon α-2a

Autor: Bazinet, M., Pantea, V., Placinta, G., Moscalu, I., Cebotarescu, V., Cojuhari, L., Jimbei, P., Iarovoi, L., Smesnoi, V., Musteata, T., Jucov, A., Krawczyk, Adalbert, Vaillant, A.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=unidue___bib::633002b691f8f7ae585b5cbfeb666359

A comparison of the therapeutic efficacy of Tenofovir Disoproxil Fumarate and Entecavir in patients with chronic Hepatitis-B.

Autor: Huan Wang¹ WANGHuan20232024@163.com, Liping Wu²

Publikováno v: Pakistan Journal of Medical Sciences. Nov2024, Vol. 40 Issue 10, p2390-2394. 5p.

Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg.

Autor: Shekhtman L; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA.; Network Science Institute, Northeastern University, Boston, MA, USA., Cotler SJ; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA., Hershkovich L; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA., Uprichard SL; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA., Bazinet M; Replicor Inc., 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada., Pantea V; Department of Infectious Diseases, Nicolae, Testemiţanu State University of Medicine and Pharmacy, Chișinău, Moldova., Cebotarescu V; Department of Infectious Diseases, Nicolae, Testemiţanu State University of Medicine and Pharmacy, Chișinău, Moldova., Cojuhari L; Department of Infectious Diseases, Nicolae, Testemiţanu State University of Medicine and Pharmacy, Chișinău, Moldova., Jimbei P; Toma Ciorbă Infectious Clinical Hospital, Chișinău, Moldova., Krawczyk A; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Department of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Dittmer U; Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Vaillant A; Replicor Inc., 6100 Royalmount Avenue, Montreal, Quebec, H4P 2R2, Canada. availlant@replicor.com., Dahari H; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA. hdahari@luc.edu.

Publikováno v: Scientific reports [Sci Rep] 2020 May 12; Vol. 10 (1), pp. 7837. Date of Electronic Publication: 2020 May 12.